Organization: Health Canada
Year: 2025
Month: February
Request Number: A-2024-000785
Request Summary: Adverse Drug Reactions (ADRs) for Ondansetron. Report numbers: E2B_07292216, E2B_07257754, E2B_07256411. ADRs for Pantoprazole sodium. Report numbers: E2B_07289678, E2B_07302776, E2B_07300609, E2B_07265897, E2B_07283554, 001099662. ADR for Pantoprazole magnesium. Report number: 001100340.
Disposition: Disclosed in part
Number of pages: 2085